Nektar Therapeutics (NKTR) Total Debt Growth (5y) (2016 - 2020)
Nektar Therapeutics (NKTR) Total Debt Growth (5y) (2016 - 2020) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Nektar Therapeutics | 2.04 Bn | 1.48 Bn | 3.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2020 | 32.42% |
| Dec 31, 2019 | 15.13% |
| Sep 30, 2019 | 14.71% |
| Jun 30, 2019 | 14.67% |
| Mar 31, 2019 | 14.63% |
| Dec 31, 2018 | 14.59% |
| Sep 30, 2018 | 14.55% |
| Jun 30, 2018 | 14.51% |
| Mar 31, 2018 | 14.47% |
| Dec 31, 2017 | 14.43% |
| Sep 30, 2017 | 14.39% |
| Mar 31, 2017 | 2.56% |
| Dec 31, 2016 | 2.52% |
| Sep 30, 2016 | 2.48% |